IDEX Biometrics ASA announced a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. In tranche 2, 4,813,857 total shares were offered, including underwriting shares. CEO and CFO Anders Storbråten and his company, Pinchcliffe AS, subscribed to shares, totaling 7,195,898 or 13.81% of the outstanding shares after completion of Tranche 2. Chair Morten Opstad and his company, K-konsult AS, also subscribed to shares. This information was disclosed on 23 August 2025, in compliance with EU Market Abuse Regulation and Norwegian Securities Trading Act. For more details, visit www.idexbiometrics.com.

Read more at GlobeNewswire: Mandatory disclosure of holding and notice of trade in IDEX